SWOG clinical trial number
SWOG-8991 (EST-3588) (RTOG-8815) (INT-0096)

A Phase III Study of Cisplatin plus Etoposide Combined with Standard Fractionation Thoracic Radiotherapy vs Cisplatin plus Etoposide Combined with Multiple Daily Fractionated Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer

Closed
Phase
Published
Abbreviated Title
A Phase III Study of Cisplatin plus Etoposide Combined with Standard Fractionation Thoracic Radiotherapy vs Cisplatin plus Etoposide Combined with Multiple Daily Fractionated Thoracic Radiotherapy…
Activated
02/15/1990
Closed
08/01/1992

Research committees

Lung Cancer

Publication Information Expand/Collapse

1999

Twice-daily compared with once-daily thoracic radiotherapy in limited small cell lung cancer treated concurrently with cisplatin and etoposide

AT Turrisi;K Kim;R Blum;WT Sause;RB Livingston;R Komaki;H Wagner;S Aisner;DH Johnson New England Journal of Medicine 340(4):265-271

1998

Observations after 5 year follow-up of intergroup trial 0096: 4 cycles of cisplatin(P) etoposide (E) and concurrent 45 GY thoracic radiotherapy (TRT) given in daily (QD) or twice-daily fractions followed by 25 GY PCI. Survival differencs and patterns of failure.

A Turrisi;K Kim;W Sause;R Komaki;H Wagner;S Aisner;R Livingston;R Blum;D Johnson Proc of the American Society of Clinical Oncology 17:457a(#1757

Incidence and clinical significance of variant morphology (small cell/large cell subtype) in limited stage small cell lung cancer (SCLC). A prospective analysis of an intergroup ECOG, RTOG and SWOG study.

SC Aisner;A Turrisi;KM Kim;WT Sause;RB Livingston;L Einhorn;H Wagner;D Ettinger;R Komaki;R Blum;DH Johnson Proc of the American Society of Clinical Oncology 17:458a(#1764)

Other Clinical Trials

SWOG Clinical Trial Number
S2302

PRAGMATICA - LUNG: A PROSPECTIVE RANDOMIZED STUDY OF RAMUCIRUMAB (LY3009806; NSC 749128) PLUS PEMBROLIZUMAB (MK-3475; NSC 776864) VERSUS STANDARD OF CARE FOR PARTICIPANTS PREVIOUSLY TREATED WITH IMMUNOTHERAPY FOR STAGE IV OR RECURRENT NON-SMALL CELL LUNG CANCER
Research Committee(s)
Lung Cancer
Activated
03/06/2023
Accrual
85%
Open
Phase
SWOG Clinical Trial Number
A082002

A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
12/21/2021
Open
Phase
SWOG Clinical Trial Number
CTSU/NRG-LU007

RAndomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Research Committee(s)
Lung Cancer
Activated
08/17/2020
Open